Ind Swift Laboratories Stock Screener | Share Price & Fundamental Analysis
INDSWFTLAB
Pharmaceuticals
Screen Ind Swift Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹89.61
▼
-0.73 (-0.81%)
Share Price BSE
₹89.66
▲
0.00 (0.00%)
Market Cap
₹734.75 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.56
EPS (TTM)
₹37.25
Dividend Yield
-
Debt to Equity
0.11
52W High
₹104.25
52W Low
₹88.15
Operating Margin
1.00%
Profit Margin
4.68%
Revenue (TTM)
₹171.00
EBITDA
₹19.00
Net Income
₹8.00
Total Assets
₹1,438.00
Total Equity
₹1,173.00
Ind Swift Laboratories Share Price History - Stock Screener Chart
Screen INDSWFTLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Ind Swift Laboratories Company Profile - Fundamental Screener
Screen Ind Swift Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDSWFTLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE915B01019
Ind Swift Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen INDSWFTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,438 | 1,460 | 1,824 | 1,801 | 1,818 | 1,870 | 1,924 | 2,023 | 2,138 | 2,215 |
| Current Assets | 865 | 960 | 1,165 | 1,075 | 944 | 863 | 836 | 842 | 832 | 926 |
| Fixed Assets | 273 | 192 | 588 | 630 | 753 | 843 | 914 | 934 | 1,042 | 1,099 |
| Liabilities | ||||||||||
| Total Liabilities | 1,438 | 1,460 | 1,824 | 1,801 | 1,818 | 1,870 | 1,924 | 2,023 | 2,138 | 2,215 |
| Current Liabilities | 45 | 215 | 771 | 866 | 901 | 906 | 980 | 534 | 601 | 746 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,173 | 812 | 682 | 601 | 603 | 641 | 588 | 553 | 531 | 517 |
| Share Capital | 69 | 67 | 60 | 60 | 60 | 60 | 48 | 46 | 46 | 42 |
| Reserves & Surplus | 1,030 | 745 | 622 | 541 | 544 | 581 | 540 | 507 | 486 | 476 |
Screen INDSWFTLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 171 | 167 | 359 | 141 | 25 | 44 | 987 | 295 | 297 | 316 | 315 | 321 | 318 | 288 | 328 |
| Expenses | 151 | 149 | 147 | 132 | 24 | 43 | 437 | 236 | 224 | 250 | 267 | 259 | 252 | 227 | 270 |
| EBITDA | 19 | 18 | 211 | 9 | 1 | 1 | 549 | 59 | 73 | 66 | 47 | 62 | 66 | 60 | 58 |
| Operating Profit % | 1.00% | 2.00% | -7.00% | -6.00% | -99.00% | -29.00% | 17.00% | 18.00% | 23.00% | 19.00% | 12.00% | 17.00% | 19.00% | 19.00% | 12.00% |
| Depreciation | 7 | 7 | 7 | 6 | 0 | 0 | 20 | 14 | 13 | 14 | 9 | 15 | 16 | 16 | 82 |
| Interest | 2 | 1 | -27 | 10 | 0 | 0 | 3 | 21 | 21 | 20 | 22 | 22 | 24 | 24 | 24 |
| Profit Before Tax | 10 | 10 | 231 | -7 | 1 | 1 | 527 | 24 | 39 | 32 | 16 | 24 | 26 | 20 | -47 |
| Tax | 2 | 2 | 8 | -1 | 0 | 0 | 33 | 5 | 7 | 14 | 41 | -3 | 1 | 0 | 14 |
| Net Profit | 8 | 9 | 222 | -6 | 0 | 1 | 494 | 19 | 32 | 17 | -25 | 28 | 25 | 20 | -62 |
| EPS | 1.00 | 1.28 | 32.96 | -0.82 | 0.07 | 0.16 | 83.55 | 3.29 | 5.36 | 2.92 | -4.25 | 4.65 | 4.29 | 3.36 | -10.40 |
Ind Swift Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen INDSWFTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -26 | -187 | 195 | 150 | 135 | 125 | -64 | 73 | 96 | 79 |
| Investing Activities | -110 | -28 | -13 | 5 | -10 | -9 | -13 | -17 | -31 | -29 |
| Financing Activities | 69 | 657 | -186 | -141 | -124 | -133 | 100 | -62 | -69 | -48 |
| Net Cash Flow | -67 | 443 | -4 | 14 | 1 | -17 | 23 | -6 | -4 | 3 |
Screen INDSWFTLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Aug | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 40.94% | 40.94% | 36.77% | 39.50% | 39.50% | 42.00% | 42.00% | 42.00% |
| FII Holding | 3.07% | 4.27% | 0.00% | 0.00% | 14.80% | 0.25% | 1.26% | 0.85% |
| DII Holding | 0.91% | 0.91% | 0.00% | 0.00% | 0.68% | 8.03% | 0.94% | 0.94% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 37.61% | 41.36% | 35.11% | 34.75% | 34.96% | 30.46% | 36.69% | 36.80% |
| Other Holding | 17.46% | 12.51% | 28.12% | 25.76% | 10.06% | 19.26% | 19.11% | 19.41% |
| Shareholder Count | 28,190 | 28,709 | 28,539 | 28,892 | 43,780 | 22,439 | 25,461 | 29,536 |
Ind Swift Laboratories Dividend Screener - Share Yield Analysis
Screen INDSWFTLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Ind Swift Laboratories Index Membership - Market Screener Classification
Screen INDSWFTLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Ind Swift Laboratories Market Events Screener - Corporate Actions
Screen INDSWFTLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -11.61% | ||
| Annual General Meeting | NA | 1.99% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.83% |
| 2025-08-14 | 2025-08-14 | Merger - Demerger | 100:15 | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -1.61% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.59% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 7.93% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -12.05% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -11.38% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -2.34% |
| 2024-07-22 | 2024-07-22 | Extraordinary General Meeting | NA | 2.12% |
| 2023-10-06 | 2023-10-06 | Extraordinary General Meeting | NA | -12.80% |
Ind Swift Laboratories Competitors Screener - Peer Comparison
Screen INDSWFTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 413,693 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 171,426 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 128,575 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,875 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,581 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,859 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 91,306 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 89,459 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 69,086 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,432 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Ind Swift Laboratories Company Announcements - News Screener
Screen INDSWFTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Closure of Trading Window | View |
| 2025-12-18 | Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Reliance Upon Exemption Provided For In Regulation 10 Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For Inter-Se Transfer Of Shares | View |
| 2025-12-18 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-15 | Receipt Of Good Manufacturing Practice (GMP) Certificate From National Center For Public Health And Pharmacy (NNGYK-Hungary). | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-05 | Intimation Of Trading Approval Obtained From Stock Exchanges For 8124698 Equity Shares Of ?10/- Each Issued Pursuant To The Approved Scheme Of Amalgamation | View |
| 2025-11-21 | Intimation Regarding Receipt Of ISO 14001:2015 And ISO 45001:2018 Certifications | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-14 | Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-07 | Board Meeting Intimation for Meeting To Be Held On 14/11/2025 | View |
| 2025-11-04 | UPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATION | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-12 | Intimation Regarding Outcome Of The Meeting Of Investment Committee Of The Board. | View |
| 2025-09-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-10 | Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Reliance Upon Exemption Provided For In Regulation 10 Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For Inter-Se Transfer Of Shares | View |
| 2025-09-09 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |